Recently, it has been proven that TLR7 activation causes endothelial dysfunction [16] and hypertension [17], and further underscored the augmented vascular inflammation and oxidative stress, facilitated partially by IL-17, as crucial elements conducive to cardiovascular complications [17]. The gene discussed is IL17A; the disease is endothelial dysfunction.